AKT1 and acute lymphoblastic leukemia: This distinction could be due to the fact that EphB receptors, including EphB6, act in T-ALL cells in a completely different molecular context, which collectively allows them to activate the AKT kinase, initiating anti-apoptotic signaling and supporting cell survival [31].